| Title | Consultation response to the Medicines and Healthcare Products Regulatory Agency on 'MLX 298 - Supplementay Prescribing: Use of Unlicensed Medicines, Reformulation of Licensed Products and Preparations Made from Active Pharmaceutical Ingredients and Excipients' |